tiprankstipranks
Travere Therapeutics (TVTX)
NASDAQ:TVTX

Travere Therapeutics (TVTX) Similar Stocks

Compare
463 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Top Analysts' Price Target
Smart Score
Follow
Travere Therapeutics
$19.68
$1.75B
159.97%
13 Buy
1 Hold
0 Sell
Strong Buy
Amgen
$306.95
$164.90B
40.60
12.26%
11 Buy
6 Hold
1 Sell
Moderate Buy
BioMarin Pharmaceutical
$71.44
$13.63B
32.48
-18.58%
19 Buy
5 Hold
0 Sell
Strong Buy
Vertex Pharmaceuticals
$492.69
$126.52B
17.74%
16 Buy
10 Hold
1 Sell
Moderate Buy
Sarepta Therapeutics
$70.41
$6.83B
29.54
-45.10%
16 Buy
3 Hold
1 Sell
Strong Buy
Ultragenyx Pharmaceutical
$37.82
$3.50B
-19.00%
16 Buy
1 Hold
0 Sell
Strong Buy

Performance Comparison

Ticker
Company Name
Price
Change
% Change
TVTX
Travere Therapeutics
19.68
12.37
169.22%
AMGN
Amgen
306.95
32.28
11.75%
BMRN
BioMarin Pharmaceutical
71.44
-15.66
-17.98%
VRTX
Vertex Pharmaceuticals
492.69
72.21
17.17%
SRPT
Sarepta Therapeutics
70.41
-57.99
-45.16%
RARE
Ultragenyx Pharmaceutical
37.82
-9.15
-19.48%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis